These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 35452102)
1. Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals. De Marco L; D'Orso S; Pirronello M; Verdiani A; Termine A; Fabrizio C; Capone A; Sabatini A; Guerrera G; Placido R; Sambucci M; Angelini DF; Giannessi F; Picozza M; Caltagirone C; Salvia A; Volpe E; Balice MP; Rossini A; Rötzschke O; Giardina E; Battistini L; Borsellino G JAMA Netw Open; 2022 Apr; 5(4):e2210871. PubMed ID: 35452102 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals. Emmelot ME; Vos M; Boer MC; Rots NY; van Els CACM; Kaaijk P Viruses; 2022 Dec; 15(1):. PubMed ID: 36680141 [TBL] [Abstract][Full Text] [Related]
3. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals. Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550 [TBL] [Abstract][Full Text] [Related]
4. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637 [TBL] [Abstract][Full Text] [Related]
5. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine. Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581 [TBL] [Abstract][Full Text] [Related]
6. Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab. Madelon N; Heikkilä N; Sabater Royo I; Fontannaz P; Breville G; Lauper K; Goldstein R; Grifoni A; Sette A; Siegrist CA; Finckh A; Lalive PH; Didierlaurent AM; Eberhardt CS JAMA Neurol; 2022 Apr; 79(4):399-404. PubMed ID: 35212717 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron. Mazzoni A; Vanni A; Spinicci M; Capone M; Lamacchia G; Salvati L; Coppi M; Antonelli A; Carnasciali A; Farahvachi P; Giovacchini N; Aiezza N; Malentacchi F; Zammarchi L; Liotta F; Rossolini GM; Bartoloni A; Cosmi L; Maggi L; Annunziato F Front Immunol; 2022; 13():801431. PubMed ID: 35154116 [TBL] [Abstract][Full Text] [Related]
9. T-cell responses to ancestral SARS-CoV-2 and Omicron variant among unvaccinated pregnant and postpartum women living with and without HIV in South Africa. McMahon WC; Kwatra G; Izu A; Jones SA; Mbele NJ; Jafta N; Lala R; Shalekoff S; Tiemessen CT; Madhi SA; Nunes MC Sci Rep; 2024 Sep; 14(1):20348. PubMed ID: 39223211 [TBL] [Abstract][Full Text] [Related]
10. BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality. Jung MK; Jeong SD; Noh JY; Kim DU; Jung S; Song JY; Jeong HW; Park SH; Shin EC Nat Microbiol; 2022 Jun; 7(6):909-917. PubMed ID: 35577972 [TBL] [Abstract][Full Text] [Related]
11. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants. Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053 [TBL] [Abstract][Full Text] [Related]
12. Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variant. Nesamari R; Omondi MA; Baguma R; Höft MA; Ngomti A; Nkayi AA; Besethi AS; Magugu SFJ; Mosala P; Walters A; Clark GM; Mennen M; Skelem S; Adriaanse M; Grifoni A; Sette A; Keeton RS; Ntusi NAB; Riou C; Burgers WA Cell Host Microbe; 2024 Feb; 32(2):162-169.e3. PubMed ID: 38211583 [TBL] [Abstract][Full Text] [Related]
13. Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination. Fries L; Formica N; Mallory RM; Zhou H; Plested JS; Kalkeri R; Moldovan I; Patel N; Albert G; Robinson M; Cho I; Chau G; Dubovsky F; Glenn GM; J Infect Dis; 2023 Sep; 228(6):734-741. PubMed ID: 37210741 [TBL] [Abstract][Full Text] [Related]
14. Reduced binding activity of vaccine serum to omicron receptor-binding domain. Li M; Weng S; Wang Q; Yang Z; Wang X; Yin Y; Zhou Q; Zhang L; Tao F; Li Y; Jia M; Yang L; Xin X; Li H; Kang L; Wang Y; Wang T; Li S; Kong L Front Immunol; 2022; 13():960195. PubMed ID: 35967350 [TBL] [Abstract][Full Text] [Related]
15. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235 [TBL] [Abstract][Full Text] [Related]
17. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Naranbhai V; Nathan A; Kaseke C; Berrios C; Khatri A; Choi S; Getz MA; Tano-Menka R; Ofoman O; Gayton A; Senjobe F; Zhao Z; St Denis KJ; Lam EC; Carrington M; Garcia-Beltran WF; Balazs AB; Walker BD; Iafrate AJ; Gaiha GD Cell; 2022 Mar; 185(6):1041-1051.e6. PubMed ID: 35202566 [TBL] [Abstract][Full Text] [Related]